Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Meanwhile, Eli Lilly's weight loss drug Zepbound and diabetes treatment ... Latest in health-care tech: Doctors seeing benefits from AI, but feel pessimistic about the future of the U.S. health ...

Novo Nordisk is taking aim at its rival, Eli Lilly, with a new obesity drug deal. On Monday ... Doctors seeing benefits from AI, but feel pessimistic about the future of the U.S. health-care ...

Investing.com -- U.S. pharmaceutical company Eli Lilly (NYSE:LLY) has introduced its diabetes and weight-loss drug Mounjaro in India ... with the support of AI and reviewed by an editor.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug development. This article is part of "AI ...